Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. (Q54252441)

26 May 2018

title

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. (English)

1 reference

26 May 2018

0 references

1 reference

irritable bowel syndrome

1 reference

Kang Nyeong Lee

0 references

Jun Sik Yoon

1 reference

26 May 2018

Won Sohn

1 reference

26 May 2018

Oh Young Lee

1 reference

26 May 2018

Sang Pyo Lee

1 reference

26 May 2018

Dae Won Jun

1 reference

26 May 2018

Hang Lak Lee

1 reference

26 May 2018

Byung Chul Yoon

1 reference

26 May 2018

Ho Soon Choi

1 reference

26 May 2018

Won-Seok Chung

1 reference

26 May 2018

Jae-Gu Seo

1 reference

26 May 2018

publication date

1 January 2014

1 reference

26 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

26 May 2018

volume

1 reference

26 May 2018

issue

1 reference

26 May 2018

page(s)

52-59

1 reference

26 May 2018

The Effect of Irritable Bowel Syndrome on Health-Related Quality of Life and Health Care Expenditures

cites work

1 reference

Clinical practice. Irritable bowel syndrome

21 January 2018

1 reference

Current and novel therapeutic options for irritable bowel syndrome management

21 January 2018

1 reference

The impact of the gut microbiota on human health: an integrative view

21 January 2018

1 reference

Intestinal microbiota in functional bowel disorders: a Rome foundation report

21 January 2018

1 reference

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

21 January 2018

1 reference

Irritable bowel syndrome, gut microbiota and probiotics.

21 January 2018

1 reference

Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome

21 January 2018

1 reference

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

21 January 2018

1 reference

Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport

21 January 2018

1 reference

The rationale and clinical effectiveness of probiotics in irritable bowel syndrome

21 January 2018

1 reference

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

Effect of probiotics on symptoms in korean adults with irritable bowel syndrome

21 January 2018

1 reference

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes

21 January 2018

1 reference

Impact of a synbiotic food on the gut microbial ecology and metabolic profiles

21 January 2018

1 reference

Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine

21 January 2018

1 reference

Cytochrome P450 alkane hydroxylases of the CYP153 family are common in alkane-degrading eubacteria lacking integral membrane alkane hydroxylases

21 January 2018

1 reference

Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.

21 January 2018

1 reference

Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction.

21 January 2018

1 reference

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria

21 January 2018

1 reference

Treating irritable bowel syndrome with probiotics: the evidence

21 January 2018

1 reference

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life

21 January 2018

1 reference

Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics

21 January 2018

1 reference

Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR.

21 January 2018

1 reference

Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii

21 January 2018

1 reference

Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula.

21 January 2018

1 reference

Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12322

1 reference

26 May 2018

1 reference

26 May 2018